Document is current
Any future updates will be listed below
-
Authors
Petermann-Rocha, Fanny https://orcid.org/0000-0002-4384-4962
Zhou, Ziyi
Mathers, John C. https://orcid.org/0000-0003-3406-3002
Celis-Morales, Carlos https://orcid.org/0000-0003-2612-3917
Raubenheimer, David
Sattar, Naveed https://orcid.org/0000-0002-1604-2593
Pell, Jill P. https://orcid.org/0000-0002-8898-7035
Forrest, Ewan
Ho, Frederick K. https://orcid.org/0000-0001-7190-9025
- License Information
-
More Information
Article History
Received: 4 January 2024
Accepted: 5 August 2024
First Online: 11 August 2024
Competing interests
: N.S. declares consulting fees and/or speaker honoraria from Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, and Sanofi; and grant support paid to his university from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics. None of these disclosures are directly related to the study, nor its conception, analyses or interpretation. The other authors declare no conflict of interest.
